Clinical Trials in Nashville

Showing 5381-5400 of 15,379 trials

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

NCT02493530

This is a Phase 1, open-label, study of TGR-1202, a PI3K delta inhibitor, administered together with ruxolitinib in patients with myeloproliferative neoplasms (specifically: polycythemia vera, primary myelofibrosis, PPV-MF or PET-MF) and MDS/MPN.

MyelofibrosisPolycythemia Vera

Vanderbilt-Ingram Cancer Center60 participantsStarted Jul 2015

Phoenix, Arizona, United States • Aurora, Colorado, United States • Nashville, Tennessee, United States +2 more locations

COMPLETEDPhase 317 miles

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677543

The primary objective of this study is to generate evidence demonstrating the domain specification (via modern psychometric methods), reliability, validity, and responsiveness (within-subject meaningful change) of the Patient-Reported Outcome (PRO) endpoints.

Mycobacterium Infections, Nontuberculous

Insmed Incorporated99 participantsStarted Dec 2020

Birmingham, Alabama, United States • Fresno, California, United States • San Diego, California, United States +59 more locations

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Find Trials by Condition in Nashville

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

Teaching Loved Ones to Help Veterans Optimize Their PTSD Care and Healing

Efficacy of Ginseng for Patients on Regorafenib

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout